1 / 31

SEPSIS

SEPSIS. Intern Bootcamp Scott Denstaedt, PGYIII. Sepsis  /ˈsɛpsɨs/; from the Greek σῆψις: the state of putrefaction and decay. Background. local inflammation  systemic inflammatory response  tissue hypoperfusion and multi-organ failure  DEATH

lucius
Download Presentation

SEPSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SEPSIS Intern Bootcamp Scott Denstaedt, PGYIII

  2. Sepsis /ˈsɛpsɨs/; from the Greek σῆψις: the state of putrefaction and decay

  3. Background • local inflammation systemic inflammatory response tissue hypoperfusion and multi-organ failure DEATH • release of specific toxins eg. Gram Negative Bacteria lipid A, Staph. aureus TSST-1 • Host cytokine response eg. TNF-alpha • Septic shock with multi-organ failure is most common cause of death in ICU • >750000 cases/year, mortality rate of 1 in 4

  4. ***Sepsis is a spectrum of illness that requires early intervention to prevent complications and progression***

  5. Definitions • Systemic Inflammatory Response Syndrome (SIRS) criteria • response to infectious and non-infectious insults • 2 criterianeeded to meet SIRS • Temp >38, <36 • HR >90 • RR >20, PaCO2 <32 (differs depending on textbook) • WBC >12k or <4k or 10% bands • *NO BLOOD PRESSURE IN SIRS CRITERIA

  6. Definitions • Sepsis • 2 SIRS criteria + source of infection (you don’t necessarily need concrete evidence – high level of clinical suspicion is enough)

  7. Definitions • Severe Sepsis • Sepsis with organ dysfunction (don’t memorize the list below) • Sepsis-induced hypotension • Lactate above upper limits laboratory normal • Urine output <0.5 mL kg/h for more than 2 h despite adequate fluid resuscitation • Acute lung injury with PaO2/FiO2<250 in the absence of pneumonia as infection source • Acute lung injury with PaO2/FiO2<200 in the presence of pneumonia as infection source • Creatinine[2.0 mg/dL (176.8 lmol/L) • Bilirubin[2 mg/dL (34.2 lmol/L) • Platelet count <100,000 lL • Coagulopathy (INR >1.5)

  8. Definitions • Septic Shock • Sepsis induced hypotension despite adequate fluid resuscitation • Sepsis induced hypotension = SBP <90mmhg or 40mmhg change from baseline

  9. Each term describes the the intensity of infectious insult • Increase in # of SIRScriteria associated with decreased intervalto progression of severe sepsis and septic shock

  10. ***CAVEATS*** • Elderly, uremic, and patients with end-stageliver diseaseor those receiving corticosteroidsmay NOT have fevers. • SIRS Criteria are entirely non-specific • EG. Everyone met SIRS criteria on day one of intern year • Clinical picture must be taken into account

  11. Rivers et. al 2001 • Initial 6 hours of resuscitation in ED • ~1-1.5 hours to identification of sepsis on avg.

  12. Early Goal Directed Therapy Outcomes • Severe Sepsis and Septic Shock • Randomized to standard therapy (iv fluids, abx) v. Early Goal Directed Therapy • RESULTS (Patients with EGDT): • Elevated CVP, MAP, Scv02 • Decreased Lactate • Improved Mortality(almost 50% reduction in mortality compared to standard therapy!!)

  13. Surviving Sepsis Campaign • Global initiative to reduce mortality from sepsis • Evidence based guidelines for the management of sepsis • Evidence graded based on LEVEL OF RECOMMENDATION(strong v. weak) and QUALITY OF EVIDENCE(ABCD) • First published 2003, revised 2008, revised again 2012

  14. Diagnosis: • 2 sets of blood culturesfrom separate sites(culture ALL vascular devices unless <48 hours old) BEFORE antibiotics(1C) • Imaging studies promptly performed to confirm potential source (UG) • Antimicrobial Therapy: • Administration of effective antimicrobials within 1 hourof recognition of septic shock (1B) or severe sepsis (1C) • Initial empiric therapyagainst all likely pathogens and that penetrate adequately into tissue presumed to be the source of sepsis (1B) • DAILY reassessment for de-escalation (1B) • Source Control: • seek and diagnose a source - if possible remove itwithin 12 hours (1C)

  15. Initial resuscitation: • Protocolized resuscitation (Early Goal Directed therapy) during first 6 hours(1C) • Abnormal lactate should be re-checked, and normalization sought (2B) • Crystalloids initial fluid of choice (1B) • Hydroxyethyl starches for fluid resuscitation should not be used (1B) • Albumin in severe sepsis and septic shock in patients who require substantial amounts of crystalloid (2C) • Initial fluid challenge = 30ml/kg(1C) • Continue fluid challenge technique as along as there is hemodynamic improvement(UG)

  16. Vasopressors: • Norepinephrine initialpressor (1B) • Epinephrine addedto or as substitute for norepinephrine (2B) • Vasopressin 0.03 added to NEto reach MAP or decrease dosage of NE (UG) • Dopamine only in highly selected patients(due to risk of arrhythmia) (2C) • Pheynlephrine only if arrhythmiawith NE or as a salvage therapy (1C) • Low dose dopaminefor renal protection should not be used(1A) • All patients on vasopressors should receive arterial catheters(UG)

  17. Steroids: • NO STEROIDS if initial resuscitation (fluid/pressors) adequate. If this is not achievable, we suggest intravenous hydrocortisone alone at a dose of 200 mg per day (2C). • Blood product administration: • transfuse only when Hgb <7g/dl to target of 7-9in the absence of extenuating cricumstances (1B) • FFP should not be usedto correct coagulopathy in the absence of bleeding or planned procedure (2D) • transfuse prophylactically when platelets <10k or <20k if significant risk of bleeding, goal of >50k if active bleeding, surgery or invasive procedure(2D)

  18. Mechanical ventilation (ARDS) • another lecture all together • Sedation: • minimize sedation and titrate to sepcific endpoints 1B • Neuromuscular blocking agents avoided if possible if no ARDS 1C • Glucose control: • initialize protocolized glucose management when 2 blood glucose levels >180 (insulin gtt), target goal <180 1A • DVT prophy and Stress ulcer prophy: • LMWH when possible in severe sepsis 1B, Dalteparin if CrCl <30 • PPI or H2RA in severe sepsis, septic shock 1B • Nutrition: • enteral or oral feeding as tolerated in first 48 hours 2C • Goals of care: • set goals of care 1B • address as early as feasibile, no later than 72 hours after admission 2C

  19. 2008 compared to 2012 • Crystalloid initial fluid of choice • Epinephrine 2nd pressor of choice • Dopamine no longer recommended • Activated protein C no longer recommended • Normalization of lactate as an endpoint in sepsis induced hypoperfusion • Use of 1,3-B-D Glucan and antigalactomannan antibodies if concern for invasive candidal infection

  20. Your Septic Patient: H+P • age • infectious review of systems: fever/chills, fatigue, myalgias, cognition, HA, sensitivity to light, rhinorrhea, sore throat, neck stiffness, cough, sob, cp, n/v/d, abdominal pain, back pain, dysuria, frequency, skin changes or wounds, recent sick contacts, recent antibiotics • medical comorbidities (chronic diseases etc.) • medications: immunosuppressants

  21. Your Septic Patient: Exam • vitals Temp, HR, RR, BP (stable or not) • head and neck (meningeal signs, oropharynx, sinuses), cardiac (murmurs!),respiratory (signs of consolidation), back (CVA,spinal/paraspinal) tenderness, abdomen, ascites, skin exam for wounds, feet!

  22. Your Septic Patient: Labs • WBC - %PMN, %bands • Hgb and Plt (important for sepsis and DIC) • BUN/Cr • Anion Gap • LFT (Hyperbilirubinemia in sepsis, also shock liver) • INR (to assess for DIC) • Lactate if hypotension, anion gap, ill appearing • ABG if anion gap, hypoxic, obtunded (pH <7.2-7.25 --> patient belongs in ICU) • U/A, Urine culture • Blood cultures from two different sites • Culture other sites as necessitated by history and exam

  23. Your Septic Patient: Imaging • CXR • Other imaging depending on your clinical suspicion (usually CT with contrast)

  24. Your Septic Patient: Treatment • Empiric therapy based on suspected source of infection • Supportive Care • Early Goal Directed Therapy • Surviving Sepsis Campaign, update 2012

  25. Clinical Method • Identify your septic patient (based on the definitions) • Triage level of care (Floor v ICU) • Work-up and treat their underlying infection • Resuscitate according to EGDT and Surviving Sepsis Campaign • Initial fluid resuscitation 30mL/kg as fast as possible, unless CHF/low EF • If in MICU place central line, arterial line

  26. Clinical Pearls • Managing Sepsis on the floor: • Use defined endpointsfor fluid resuscitation • U/O >0.5cc/kg/hr • MAP >65 • Normalization of lactate • KNOW the patients Ejection Fractionand renal function • Fluid resuscitation is the priority!!! • Start pressors if MAP <65, even if CVP not yet known • Transfer to MICU: • Hypotension resistant to fluid resuscitation (Septic shock) – usually after 4-6L fluid • Severe lactic acidosis (pH 7.2-7.25) • Severe or acutely worsening hypoxia or obtundation

  27. Sources • Rivers et. al Early Goal Directed Therapy, NEJM 2001 • Dellinger et. al Surviving Sepsis Campaign 2012, Intensive Care Med 2013 • Current Diagnosis and Treatment: Critical Care, 3rd Edition • http://www.youtube.com/watch?v=MceGURfXdR0

More Related